193P Adjuvant endocrine therapy in patients with breast cancer: Relationship between side effects, quality of life and treatment adherence

Abstract

Background: Several studies have shown improvement in pCR rate with the addition of carboplatinum to the neo-adjuvant chemotherapy (NACT) treatment of stage I-III triple-negative breast cancer (TNBC). However, data on its effects on long-term outcomes such as relapse-free survival and overall survival is not well known. Furthermore, data from ongoing studies addressing these outcomes are currently awaited. We intended to assess pCR, RFS, and OS in this population using our realworld data. abstracts Annals of OncologyVolume 32 -Issue S5 -2021 S441

Adherence to oral hormonal therapy in advanced prostate cancer: a scoping review

“…In early breast cancer, low rates of adherence to oral hormonal therapy have been linked to reduced survival and potentially quality of life. 73–80 While the retrospective analysis by Cindolo et al 65 failed to demonstrate an association between OS and adherence rates ( p = 0.98), Banna et al 48 found an association between nonadherence and radiological response by receiver operating characteristic curve analysis but not with radiological progression-free survival or OS. A strong correlation between OS and duration of abiraterone treatment was identified by Al-Ali et al 62 in their retrospective analysis of the claims database from the largest insurance company in Austria.…”

“…In early breast cancer, low rates of adherence to oral hormonal therapy have been linked to reduced survival and potentially quality of life. [73][74][75][76][77][78][79][80] While the retrospective analysis by Cindolo et al 65 failed to demonstrate an association between OS and adherence rates (p = 0.98), Banna et al 48 found an association between…”